ArticleJournal of cancer immunology2024

A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer.

Ricardo A León-Letelier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.